The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pan, L. Y.
Right arrow Articles by Guyre, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pan, L. Y.
Right arrow Articles by Guyre, P. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYCLOHEXIMIDE
*DACTINOMYCIN
*DEXAMETHASONE

The Journal of Immunology, Vol 145, Issue 1 267-275, Copyright © 1990 by American Association of Immunologists


ARTICLES

Regulation of the steady state level of Fc gamma RI mRNA by IFN-gamma and dexamethasone in human monocytes, neutrophils, and U-937 cells

LY Pan, DB Mendel, J Zurlo and PM Guyre
Department of Physiology, Dartmouth Medical School, Hanover, NH 03756.

The high affinity IgG FcR Fc gamma RI, CD64, plays important roles in the immune response. Fc gamma RI is predominantly expressed on monocytes and macrophages, and barely detectable on neutrophils. rIFN- gamma markedly increases the expression of Fc gamma RI on neutrophils, monocytes, macrophages and myeloid cell lines such as U-937, HL-60, and THP-1. Glucocorticoids inhibit the augmentation of Fc gamma RI expression by rIFN-gamma on neutrophils and myeloid cell lines, but enhance the augmentation of Fc gamma RI expression by rIFN-gamma on monocytes. In this study, we examined the effect of rIFN-gamma and dexamethasone (Dex) on the steady state level of Fc gamma RI mRNA in U- 937 cells, neutrophils, and monocytes by hybridizing total RNA with the Fc gamma RI cDNA probe, p135. We found that the amount of Fc gamma RI mRNA increased within 1 h of treatment with rIFN-gamma in all three cell types. This initial induction of Fc gamma RI mRNA by rIFN-gamma was completely blocked by an inhibitor of RNA synthesis, actinomycin D, suggesting that the rIFN-gamma-mediated induction of Fc gamma RI mRNA is dependent on gene transcription. Dex, used in combination with rIFN- gamma, partially blocked the induction of Fc gamma RI mRNA by rIFN- gamma in U-937 cells and neutrophils, but caused a synergistic increase in Fc gamma RI mRNA levels in monocytes. The inhibitory effect of Dex on the steady state level of Fc gamma RI mRNA in U-937 cells was blocked by an inhibitor of protein synthesis, cycloheximide, suggesting that Dex-induced proteins were involved in the regulation of Fc gamma RI expression. This study indicates that the regulation of Fc gamma RI expression on U-937 cells, neutrophils, and monocytes by rIFN-gamma and Dex occurs, at least in part, at the mRNA level. rIFN-gamma increases the steady state level of Fc gamma RI mRNA through a common pathway among U-937 cells, neutrophils, and monocytes, whereas the effect of Dex on rIFN-gamma-induced Fc gamma RI mRNA is cell-type specific.


This article has been cited by other articles:


Home page
Protein Eng Des SelHome page
G. Berntzen, O.H. Brekke, S.A. Mousavi, J.T. Andersen, T.E. Michaelsen, T. Berg, I. Sandlie, and V. Lauvrak
Characterization of an Fc{gamma}RI-binding peptide selected by phage display
Protein Eng. Des. Sel., March 1, 2006; 19(3): 121 - 128.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Tridandapani, K. Siefker, J.-L. Teillaud, J. E. Carter, M. D. Wewers, and C. L. Anderson
Regulated Expression and Inhibitory Function of Fcgamma RIIb in Human Monocytic Cells
J. Biol. Chem., February 8, 2002; 277(7): 5082 - 5089.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
T. Musso, S. Deaglio, L. Franco, L. Calosso, R. Badolato, G. Garbarino, U. Dianzani, and F. Malavasi
CD38 expression and functional activities are up-regulated by IFN-{gamma} on human monocytes and monocytic cell lines
J. Leukoc. Biol., April 1, 2001; 69(4): 605 - 612.
[Abstract] [Full Text]


Home page
CVIHome page
M. Beigier-Bompadre, P. Barrionuevo, F. Alves-Rosa, C. J. Rubel, M. S. Palermo, and M. A. Isturiz
N-Formyl-Methionyl-Leucyl-Phenylalanine Inhibits both Gamma Interferon- and Interleukin-10-Induced Expression of Fc{gamma}RI on Human Monocytes
Clin. Vaccine Immunol., March 1, 2001; 8(2): 402 - 408.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Aittomaki, M. Pesu, B. Groner, O. A. Janne, J. J. Palvimo, and O. Silvennoinen
Cooperation Among Stat1, Glucocorticoid Receptor, and PU.1 in Transcriptional Activation of the High-Affinity Fc{gamma} Receptor I in Monocytes
J. Immunol., June 1, 2000; 164(11): 5689 - 5697.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Pricop, J. Gokhale, P. Redecha, S. C. Ng, and J. E. Salmon
Reactive Oxygen Intermediates Enhance Fc{gamma} Receptor Signaling and Amplify Phagocytic Capacity
J. Immunol., June 15, 1999; 162(12): 7041 - 7048.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. L. Maresco, J. M. Osborne, D. Cooney, K. M. Coggeshall, and C. L. Anderson
The SH2-Containing 5'-Inositol Phosphatase (SHIP) Is Tyrosine Phosphorylated after Fc{gamma} Receptor Clustering in Monocytes
J. Immunol., June 1, 1999; 162(11): 6458 - 6465.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. G. Ericson, Y. Zhao, H. Gao, K. L. Miller, L. F. Gibson, J. P. Lynch, and K. S. Landreth
Interleukin-6 Production by Human Neutrophils After Fc-Receptor Cross-Linking or Exposure to Granulocyte Colony-Stimulating Factor
Blood, March 15, 1998; 91(6): 2099 - 2107.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. C. Pfefferkorn, J. G. J. van de Winkel, and S. L. Swink
A Novel Role for IgG-Fc
J. Biol. Chem., April 7, 1995; 270(14): 8164 - 8171.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. S. Schwartz
Treating Chronic Idiopathic Thrombocytopenic Purpura -- A New Application of an Old Treatment
N. Engl. J. Med., June 2, 1994; 330(22): 1609 - 1610.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.